Synsam AB (CHIX:SYNSAS) Beneish M-Score: -3.36 (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:SYNSAS Synsam AB CHIX:SYNSAS
85 GF Score
Price kr59.80
GF Value kr64.34
! 1 Warning Sign
View Full Analysis

What is Synsam AB Beneish M-Score?

Synsam AB CHIX:SYNSAS 85 Beneish M-Score is -3.36 as of Aug. 05, 2026. GuruFocus rates CHIX:SYNSAS with a GF Score™ of 85/100 and a GF Value™ of kr64.34. The stock has 1 warning sign investors should review. Among 762 Medical Devices & Instruments companies, Synsam AB ranks better than 86.48% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.36 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Synsam AB's Beneish M-Score or its related term are showing as below:

CHIX:SYNSAs' s Beneish M-Score Range Over the Past 10 Years
Min: -3.36   Med: -2.75   Max: -2.29
Current: -3.36

During the past 8 years, the highest Beneish M-Score of Synsam AB was -2.29. The lowest was -3.36. And the median was -2.75.


Synsam AB Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Synsam AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synsam AB Beneish M-Score Chart

Synsam AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -2.85 -2.39 -2.80 -2.62 -3.36

Synsam AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.36 0.00

CHIX:SYNSAS vs ISRG, BDX, MDLN: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Synsam AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synsam AB Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Synsam AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Synsam AB's Beneish M-Score falls into.


CHIX:SYNSAS
85GF Score
Synsam AB CHIX:SYNSAS
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synsam AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Synsam AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.4699+0.528 * 1.0121+0.404 * 0.9917+0.892 * 1.1038+0.115 * 0.9529
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.102203-0.327 * 1.0017
=-3.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was kr389 Mil.
Revenue was kr7,200 Mil.
Gross Profit was kr5,379 Mil.
Total Current Assets was kr1,956 Mil.
Total Assets was kr7,945 Mil.
Property, Plant and Equipment(Net PPE) was kr1,586 Mil.
Depreciation, Depletion and Amortization(DDA) was kr826 Mil.
Selling, General, & Admin. Expense(SGA) was kr0 Mil.
Total Current Liabilities was kr1,812 Mil.
Long-Term Debt & Capital Lease Obligation was kr3,178 Mil.
Net Income was kr454 Mil.
Gross Profit was kr0 Mil.
Cash Flow from Operations was kr1,266 Mil.
Total Receivables was kr750 Mil.
Revenue was kr6,523 Mil.
Gross Profit was kr4,932 Mil.
Total Current Assets was kr2,033 Mil.
Total Assets was kr8,244 Mil.
Property, Plant and Equipment(Net PPE) was kr1,604 Mil.
Depreciation, Depletion and Amortization(DDA) was kr777 Mil.
Selling, General, & Admin. Expense(SGA) was kr0 Mil.
Total Current Liabilities was kr2,079 Mil.
Long-Term Debt & Capital Lease Obligation was kr3,090 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(389 / 7200) / (750 / 6523)
=0.054028 / 0.114978
=0.4699

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4932 / 6523) / (5379 / 7200)
=0.756094 / 0.747083
=1.0121

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1956 + 1586) / 7945) / (1 - (2033 + 1604) / 8244)
=0.554185 / 0.558831
=0.9917

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=7200 / 6523
=1.1038

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(777 / (777 + 1604)) / (826 / (826 + 1586))
=0.326333 / 0.342454
=0.9529

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 7200) / (0 / 6523)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3178 + 1812) / 7945) / ((3090 + 2079) / 8244)
=0.628068 / 0.627001
=1.0017

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(454 - 0 - 1266) / 7945
=-0.102203

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Synsam AB has a M-score of -3.36 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.36 mean?
Synsam AB (CHIX:SYNSAS) has a Beneish M-Score of -3.36 as of Aug. 05, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Synsam AB and its competitors. According to the industry distribution chart, Synsam AB ranks #103 out of 762 companies in the Medical Devices & Instruments industry, placing it in the top 13.5%.
Is Synsam AB's Beneish M-Score too high?
Synsam AB's current Beneish M-Score is -3.36. Based on the distribution chart, Synsam AB ranks #103 out of 762 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Synsam AB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Synsam AB's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Synsam AB ranks #103 out of 762 companies for Beneish M-Score. This places Synsam AB in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Synsam AB and its competitors. Synsam AB's current Beneish M-Score is -3.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synsam AB stock overvalued right now?
Synsam AB (CHIX:SYNSAS) has a current Beneish M-Score of -3.36. The stock's GF Value™ is kr64.34, compared to a current price of kr59.80 — trading 7.1% below its estimated fair value. The current Beneish M-Score is -3.36. Synsam AB's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Synsam AB (CHIX:SYNSAS), the current Beneish M-Score is -3.36 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synsam AB (CHIX:SYNSAS) Overvalued in 2026?

Based on GuruFocus' analysis, Synsam AB stock appears to be undervalued. The current stock price of kr59.80 is trading 7.1% below its estimated GF Value™ of kr64.34.

Key valuation signals for CHIX:SYNSAS:

  • Beneish M-Score: -3.36
  • GF Value™: kr64.34 vs. price of kr59.80 (7.1% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the CHIX:SYNSAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synsam AB Business Description

Other Exchanges SYNSAM:Sweden9FZ:Germany
Address Sankt Eriksgatan 60, Stockholm, SWE, 112 34
Synsam AB is a lifestyle company in optics and eye health in the Nordic region. The company offers various products and services in physical and digital stores, such as eye examinations, spectacles, sunglasses, sports spectacles, contact lenses, and accessories in optical retail, as well as spectacles subscriptions and related services under the name Synsam Lifestyle. Its stores are operated under the Synsam brand in Sweden, Norway, and Finland, and under the Profil Optik brand in Denmark and Iceland. The company comprises four segments: Sweden, which generates key revenue, Denmark, Norway, and Finland.
85GF Score

Get the complete analysis for CHIX:SYNSAS

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr59.80
Price
kr64.34
GF Value